Replies to post #221804 on Biotech Values

[DewDiligence]

(ENTA)—Who else is working on RSV?

One such company is Reviral, a private UK company—see #msg-138812018.

The program that SNY just pared back on is the one acquired from ABLX (#msg-138983047).

If anyone reading this has an exhaustive list of RSV drug candidates in development, please post.

[oc631]

Who else is working on RSV?

VXRT claims to have a preclinical RSV program. Without digging my guess is this a cadaver from the Australian Biota reverse merger years ago; many times removed.

[dangerM]

RSV, the vaccines in development ...

... only an overview of vaccines/mAb in development, no other, but quite current:

https://www.path.org/resources/rsv-vaccine-and-mab-snapshot/

By the way, the Anti-F mAb by Medimmune/Sanofi should be MEDI8897, which I referenced to in this post

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=129203651